Can a phone app train your brain to beat the blues?
NCT ID NCT06735885
First seen Jun 27, 2026 · Last updated Jul 07, 2026 · Updated 2 times
Summary
This study tests a smartphone app called Matter Neuroscience that uses neurofeedback from brain scans to help people with mild to moderate depression better understand positive emotions. Researchers will enroll 240 adults to see if the app is safe and effective at reducing depression symptoms. The goal is to lay the groundwork for a larger, more definitive trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Matter Neuroscience App (smartphone application)
- What this could lead to
- If it works, this could point toward a new, non-drug way to ease depression symptoms using brain training at home.
- What could go wrong
- This is an early feasibility trial, so it is small and designed mainly to test safety and basic effectiveness. The app may not work for everyone, and results may not apply to severe depression.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stanford University Brain Stimulation Lab
RECRUITINGStanford, California, 94304, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a Web-Based therapy ease common mental health struggles?
- Your voice may hold clues to depression – a new device listens in
- Can a virtual meadow or a Mind's eye stream calm hospital anxiety?
- Could the sound of your voice reveal depression?
- Can MRI reveal the Brain's response to deep brain stimulation?
- Could a new drug offer hope for Treatment-Resistant depression?